Skip to main navigation Skip to search Skip to main content

Quinine-induced hearing loss

  • F. W. Nielsen-Abbring
  • , R. M. Perenboom
  • , R. J. A. M. van der Hulst*
  • *Corresponding author for this work
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Sensorineural hearing loss due to quinine therapy for malaria has frequently been mentioned in the literature but has not been a subject of research during the last decades. The global spreading of chloroquine-resistant falciparum malaria brings about an increasing use of quinine. The ototoxicity of quinine can accurately be studied with ultrahigh frequency audiometry (up to 20 kHz). The case of a 29-year-old man suffering from falciparum malaria disease who get a reversible hearing loss from quinine therapy is presented.
Original languageEnglish
Pages (from-to)65-68
JournalORL; journal for oto-rhino-laryngology and its related specialties
Volume52
Issue number1
DOIs
Publication statusPublished - 1990
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Quinine-induced hearing loss'. Together they form a unique fingerprint.

Cite this